Philippe Auclair, who has a PhD in pharmacy, joined Abbott in 1994. He is currently responsible for regulatory strategy and advocacy. He represents the European industry in various European Commission expert groups and served through 2012 as secretary of the Global Harmonization Task Force Study – Group 2, dealing with adverse events reporting. He actively participates as a trainer in programs organised by regulatory authorities in various locations, such as Europe, Colombia, Brazil, China, India, Mexico and the United States, and since 2015 he has served as an advisor to the Asian Harmonization Working Party Technical Committee.
Philippe is chairman of the post-market surveillance and notified body working groups of Medtech Europe, the European medical device manufacturers’ trade association. He is a member of the European Advisory Committee and of the board nominating committee of the Regulatory Affairs Professional Society (RAPS). Philippe received the “Global Leadership Award” from RAPS in 2010 and was elected “RAPS Fellow” in 2012. Philippe is also the proud recipient of an FDA CDRH Director’s “Special Citation” for his work at GHTF.